IBDEI0CJ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5424,1,3,0)
 ;;=3^Drug Induced Fever
 ;;^UTILITY(U,$J,358.3,5424,1,4,0)
 ;;=4^R50.2
 ;;^UTILITY(U,$J,358.3,5424,2)
 ;;=^5019507
 ;;^UTILITY(U,$J,358.3,5425,0)
 ;;=R50.9^^40^366^38
 ;;^UTILITY(U,$J,358.3,5425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5425,1,3,0)
 ;;=3^Fever,Unspec
 ;;^UTILITY(U,$J,358.3,5425,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,5425,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,5426,0)
 ;;=R53.0^^40^366^56
 ;;^UTILITY(U,$J,358.3,5426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5426,1,3,0)
 ;;=3^Neoplastic Related Fatigue
 ;;^UTILITY(U,$J,358.3,5426,1,4,0)
 ;;=4^R53.0
 ;;^UTILITY(U,$J,358.3,5426,2)
 ;;=^5019515
 ;;^UTILITY(U,$J,358.3,5427,0)
 ;;=R53.1^^40^366^75
 ;;^UTILITY(U,$J,358.3,5427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5427,1,3,0)
 ;;=3^Weakness
 ;;^UTILITY(U,$J,358.3,5427,1,4,0)
 ;;=4^R53.1
 ;;^UTILITY(U,$J,358.3,5427,2)
 ;;=^5019516
 ;;^UTILITY(U,$J,358.3,5428,0)
 ;;=R53.81^^40^366^53
 ;;^UTILITY(U,$J,358.3,5428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5428,1,3,0)
 ;;=3^Malaise NEC
 ;;^UTILITY(U,$J,358.3,5428,1,4,0)
 ;;=4^R53.81
 ;;^UTILITY(U,$J,358.3,5428,2)
 ;;=^5019518
 ;;^UTILITY(U,$J,358.3,5429,0)
 ;;=R53.82^^40^366^21
 ;;^UTILITY(U,$J,358.3,5429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5429,1,3,0)
 ;;=3^Chronic Fatigue,Unspec
 ;;^UTILITY(U,$J,358.3,5429,1,4,0)
 ;;=4^R53.82
 ;;^UTILITY(U,$J,358.3,5429,2)
 ;;=^5019519
 ;;^UTILITY(U,$J,358.3,5430,0)
 ;;=R53.83^^40^366^37
 ;;^UTILITY(U,$J,358.3,5430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5430,1,3,0)
 ;;=3^Fatigue NEC
 ;;^UTILITY(U,$J,358.3,5430,1,4,0)
 ;;=4^R53.83
 ;;^UTILITY(U,$J,358.3,5430,2)
 ;;=^5019520
 ;;^UTILITY(U,$J,358.3,5431,0)
 ;;=R55.^^40^366^69
 ;;^UTILITY(U,$J,358.3,5431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5431,1,3,0)
 ;;=3^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,5431,1,4,0)
 ;;=4^R55.
 ;;^UTILITY(U,$J,358.3,5431,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,5432,0)
 ;;=R56.9^^40^366^23
 ;;^UTILITY(U,$J,358.3,5432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5432,1,3,0)
 ;;=3^Convulsions,Unspec
 ;;^UTILITY(U,$J,358.3,5432,1,4,0)
 ;;=4^R56.9
 ;;^UTILITY(U,$J,358.3,5432,2)
 ;;=^5019524
 ;;^UTILITY(U,$J,358.3,5433,0)
 ;;=R68.83^^40^366^20
 ;;^UTILITY(U,$J,358.3,5433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5433,1,3,0)
 ;;=3^Chills w/o Fever
 ;;^UTILITY(U,$J,358.3,5433,1,4,0)
 ;;=4^R68.83
 ;;^UTILITY(U,$J,358.3,5433,2)
 ;;=^5019555
 ;;^UTILITY(U,$J,358.3,5434,0)
 ;;=C78.7^^40^367^91
 ;;^UTILITY(U,$J,358.3,5434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5434,1,3,0)
 ;;=3^Secondary Malig Neop of Liver/Intrahepatic Bile Duct
 ;;^UTILITY(U,$J,358.3,5434,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,5434,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,5435,0)
 ;;=C78.5^^40^367^90
 ;;^UTILITY(U,$J,358.3,5435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5435,1,3,0)
 ;;=3^Secondary Malig Neop of Large Intestine/Rectum
 ;;^UTILITY(U,$J,358.3,5435,1,4,0)
 ;;=4^C78.5
 ;;^UTILITY(U,$J,358.3,5435,2)
 ;;=^267327
 ;;^UTILITY(U,$J,358.3,5436,0)
 ;;=C78.89^^40^367^89
 ;;^UTILITY(U,$J,358.3,5436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5436,1,3,0)
 ;;=3^Secondary Malig Neop of Digestive Organs NEC
 ;;^UTILITY(U,$J,358.3,5436,1,4,0)
 ;;=4^C78.89
 ;;^UTILITY(U,$J,358.3,5436,2)
 ;;=^5001341
 ;;^UTILITY(U,$J,358.3,5437,0)
 ;;=C15.3^^40^367^83
 ;;^UTILITY(U,$J,358.3,5437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5437,1,3,0)
 ;;=3^Malig Neop of Upper Third of Esophagus
 ;;^UTILITY(U,$J,358.3,5437,1,4,0)
 ;;=4^C15.3
 ;;^UTILITY(U,$J,358.3,5437,2)
 ;;=^267059
